Found 31 matching trials
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) PHASE4 The purpose of this study is to evaluate whether maintenance antiretroviral...
Show More Location
Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel
Learn More & Join Trial
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen PHASE2 The goal of this clinical study is to learn more about the effects of switc...
Show More Status
Active Not Recruiting
Location
Be Well Medical Center
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants PHASE3 The primary objective of this study is to evaluate the efficacy of switchin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity PHASE4 This is a phase IV, open label, multicentre trial that will be taking place...
Show More Location
Chelsea and Westminster Hospital
Learn More & Join Trial
Adipose Tissue After Switch to Doravirine NA Integrase-strand-transfer-inhibitors (INSTIs) based regimens have been asso...
Show More Location
Christine Katlama
Learn More & Join Trial
Evaluating BMD in Participants ≥50 Years Old Switching From EVG/COBI/FTC/TAF or EVG/COBI/FTC/TDF to ABC/DTG/3TC NA Phase IV, Single-Arm, Open-Label Study Evaluating Bone Mineral Density in H...
Show More Location
Mills Clinical Research
Learn More & Join Trial
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens PHASE3 The goal of this clinical study is to compare how effective a long-acting t...
Show More Location
Be Well Medical Center
Learn More & Join Trial
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF PHASE3 This study will evaluate the efficacy of switching from emtricitabine/tenof...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE) PHASE3 Research hypothesis:
Switching from dual regimens based on dolutegravir pl...
Show More Location
Ospedale San Raffaele
Learn More & Join Trial